A twenty-day trial found that a few drops of peppermint oil, taken twice daily, dropped systolic blood pressure by more than eight points in adults with mild hypertension.
Quick Take
- A randomized, placebo-controlled trial of 40 adults tested peppermint oil against a peppermint-flavored placebo over 20 days.
- The peppermint group’s systolic blood pressure fell from 130.05 to 121.97, an adjusted drop of 8.48 points versus placebo.
- Participants took 100 microliters of peppermint oil daily, split into two doses.
- Researchers at the University of Lancashire call the finding a supported hypothesis, not a finished treatment.
- The study is small and short, so longer trials are needed to confirm the effect holds up over time.
What The Trial Actually Measured
Researchers at the University of Lancashire designed a straightforward test. They split 40 adults with pre-hypertension or stage 1 hypertension into two groups. One group took real peppermint oil. The other took a peppermint-flavored placebo that looked and tasted the same. Neither group knew which one they got, the gold standard for trial design.
The Numbers Behind The Headline
The peppermint group started at an average systolic reading of 130.05. After 20 days, it dropped to 121.97. The placebo group barely moved, starting at 130.93 and ending at 131.05. After adjusting for other factors, the real difference between groups came out to 8.48 points, with a confidence range that never crossed zero.
That statistical detail matters. A confidence interval that stays on one side of zero means the result is unlikely to be random chance. In plain terms, the drop in blood pressure tracked with taking the oil, not with luck or measurement noise. The researchers built their whole hypothesis around finding exactly this kind of signal, and they found it.
The dose was simple and repeatable. Participants took 100 microliters of peppermint oil each day, split into two servings. That is a small, consumer-friendly amount, the kind of routine someone could fold into a morning and evening habit without much fuss.
Why This Population Matters
The trial did not test people already on blood pressure medication or those with severe hypertension. It focused on adults sitting in that frustrating middle zone doctors call pre-hypertension or stage 1 hypertension. These are people whose numbers are creeping up but who often get told to “watch it” rather than start a prescription. An affordable oil that helps in exactly that window fills a real gap.
What The Study Does Not Yet Prove
Forty participants is a small sample for any medical claim. It limits how confidently researchers can say the effect will hold across ages, body types, or health backgrounds. Twenty days is also brief. Nobody yet knows if the drop lasts three months, a year, or fades once the body adjusts. The study’s authors describe this as a first step, not a final answer.
Broader research on the mint family gives useful context. A 2024 review of Mentha studies found blood pressure reductions that were not statistically significant across the board. That does not undercut this specific peppermint oil trial, but it does explain why doctors will likely wait for a second, larger study before changing any official guidance.
How The Story Is Spreading
Coverage moved fast once the study published, with health outlets and social media accounts repeating the 8.5-point figure almost word for word. That is a useful number, easy to remember and easy to share. It is also exactly the kind of tidy statistic that commercial supplement sellers can run with, since peppermint oil is cheap, unregulated as a drug, and already sitting on pharmacy shelves.
🌿 Peppermint oil lowers blood pressure in just 20 days!
University of Lancashire research shows peppermint oil significantly reduced blood pressure in just 20 days. pic.twitter.com/9pmI5B8h5j
— DrSciora (@DrSciora) August 22, 2026
None of that markets excitement changes what the trial actually showed. A small, well-designed, placebo-controlled study found a real, measurable drop in systolic blood pressure over 20 days. The next job for science is bigger trials, longer timelines, and confirmation from other research teams. Until then, this is a promising early result worth watching, not a replacement for a doctor’s advice or existing medication.
Sources:
sciencedaily.com, journals.plos.org, yggdrasilnaturopathic.com, ctv.veeva.com
